LDLR mutations often cause autosomal dominant hypercholesterolemia (ADH) by affecting the hepatic clearance of blood LDL-C (40), Notably, ADH is clinically characterized by high blood LDL-C and atherosclerosis that may eventually lead to CHD (41). Here, AVP is linked to coronary artery disorder.